CMPS Australia: Global Pharmaceutical Manufacturing Powering Zifam Pinnacle (Myanmar)

Contract Manufacturing & Packaging Services (CMPS) Pty Ltd is a key pharmaceutical manufacturing unit under the Zifam Pinnacle Health Care Group, Australia. Headquartered in New South Wales, CMPS is a world-class facility that supports the pharmaceutical supply chain for Zifam Myanmar and over 45 countries worldwide. With international regulatory compliance, TGA certification, and a commitment to pharmaceutical integrity, CMPS ensures that every product meets the highest standards of safety, efficacy, and quality.

 

Quality, Integrity, and Reliability – The Pillars of CMPS

At CMPS, our operations are built upon the unwavering principles of Quality, Integrity, and Reliability. These core values guide every decision and process within our manufacturing facility in Australia and extend throughout our global pharmaceutical delivery network:

Quality: Every product is manufactured under strict TGA-certified standards, ensuring it meets or exceeds global regulatory requirements. From sourcing high-grade raw materials to using validated processes and advanced quality control technologies, our focus on quality guarantees the efficacy and safety of every batch.

Integrity: We operate with full transparency and regulatory compliance, ensuring that each product adheres to ethical manufacturing practices. CMPS aligns with international standards such as PIC/S GMP and collaborates closely with health authorities to maintain the trust of patients, healthcare providers, and partners worldwide.

Reliability: With decades of experience, robust systems, and proven logistics frameworks, we deliver pharmaceutical products on time, every time. Our reliable supply chain and responsive customer service ensure that essential medicines reach over 45 countries, including Myanmar, without compromise.

Together, these values ensure that CMPS not only produces medicines but delivers trust—batch after batch, country after country.

 

TGA Certification – Australia’s Gold Standard in Pharmaceutical Regulation

The Therapeutic Goods Administration (TGA) is Australia’s regulatory authority for therapeutic goods, including medicines, medical devices, and supplements. It operates under the Department of Health and Aged Care and ensures that all pharmaceutical products meet rigorous standards for safety, efficacy, and manufacturing quality before reaching the market.

Being TGA-certified is a hallmark of global pharmaceutical excellence. Unlike many other international standards, the TGA:
– Enforces strict Good Manufacturing Practice (GMP) aligned with PIC/S standards.
– Conducts regular on-site audits and risk-based inspections.
– Requires comprehensive documentation, validation reports, and stability data.
– Demands full traceability of raw materials, packaging, processes, and release data.

Very few manufacturing facilities in Australia and globally maintain consistent TGA compliance due to its intensity and cost. CMPS is one of the elite few.

 

Uncompromising Quality Control From Start to Finish

At CMPS, quality is not a checkpoint—it is a continuous process embedded in every stage of manufacturing.

In-House Quality Control Systems:
– Advanced testing equipment in our fully equipped QC lab
– Real-time release testing methodology
– ISO-8 (Grade-D) classified cleanroom environments
– Full product lifecycle oversight—from raw material to finished goods

Batch Release & Regulatory Compliance:
– Every batch undergoes comprehensive testing, verification, and review
– Final release is conducted only by a Qualified Person (QP) or QA Head
– Complies not only with TGA, but also USFDA, Health Canada, ANVISA, WHO, and other key regulators

 

Raw Material Standards – Quality Begins at the Source

CMPS enforces an industry-leading raw material management system:
– All inputs are sourced from audited, qualified global vendors
– Pre-manufacturing tests meet BP, USP, EP, and in-house specifications
– Segregated raw material storage areas with environmental controls
– Only QA-cleared materials are released for use in production

This approach ensures our Myanmar partners and end-users benefit from clean, pure, and consistent active pharmaceutical ingredients (APIs) and excipients in every formulation.

 

Global Reach. Local Impact. Trusted Worldwide.

From its central manufacturing base in Sydney, CMPS supports a global network that spans:

Australia | Myanmar | Singapore | Thailand | India | USA | Canada | 40+ other countries in ASEAN, MENA, Africa & CIS

With end-to-end regulatory and export support, CMPS products are delivered:
– With validated shipping documentation and cold chain (as required)
– Aligned with the specific import laws of each country
– Accompanied by full batch certification and pharmacovigilance data

 

CMPS + Zifam Pinnacle (Myanmar): Elevating Healthcare, Together

CMPS ensures that Zifam Myanmar delivers pharmaceutical excellence to every clinic, pharmacy, and patient in Myanmar—built on the backbone of:

– Australian-made quality
– TGA-backed integrity
– And science-driven innovation

Our commitment is simple: to manufacture pharmaceutical products that doctors trust and patients deserve.